Paul Tudor Jones Veracyte, Inc. Transaction History

Tudor Investment Corp Et Al

$25.1 Billion
Q4 2024

A detailed history of Paul Tudor Jones (Tudor Investment Corp Et Al) transactions in Veracyte, Inc. stock. As of the latest transaction made, Tudor Investment Corp Et Al holds 20,342 shares of VCYT stock, worth $653,791. This represents 0.0% of its overall portfolio holdings.

Number of Shares

20,342

Previous 40,873 50.23%

Holding current value

$653,791

Previous $1.39 Million 42.09%

% of portfolio

0.0%

Previous 0.01%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$31.92 - $44.4 $655,349 - $911,576	-20,531 Reduced 50.23%	20,342 $805,000
Q3 2024 Nov 14, 2024	BUY	$21.0 - $35.25 $41,769 - $70,112	1,989 Added 5.12%	40,873 $1.39 Million
Q2 2024 Aug 14, 2024	BUY	$18.86 - $23.55 $733,352 - $915,718	38,884 New	38,884 $842,000
Q2 2023 Aug 14, 2023	SELL	$20.96 - $26.99 $38,377 - $49,418	-1,831 Reduced 5.12%	33,950 $864,000
Q1 2023 May 15, 2023	BUY	$20.58 - $27.89 $736,372 - $997,932	35,781 New	35,781 $798,000
Q3 2022 Nov 14, 2022	BUY	$16.58 - $27.9 $513,416 - $863,951	30,966 New	30,966 $514,000
Q2 2022 Aug 15, 2022	SELL	$15.45 - $29.52 $372,097 - $710,959	-24,084 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$21.94 - $42.51 $97,567 - $189,041	4,447 Added 22.65%	24,084 $664,000
Q4 2021 Feb 14, 2022	BUY	$36.09 - $53.79 $708,699 - $1.06 Million	19,637 New	19,637 $809,000
Q3 2021 Nov 15, 2021	SELL	$35.62 - $52.97 $685,649 - $1.02 Million	-19,249 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$32.94 - $56.62 $472,326 - $811,874	14,339 Added 292.04%	19,249 $770,000
Q1 2021 May 17, 2021	SELL	$44.47 - $81.38 $931,690 - $1.7 Million	-20,951 Reduced 81.01%	4,910 $264,000
Q4 2020 Feb 16, 2021	BUY	$32.49 - $61.88 $840,223 - $1.6 Million	25,861 New	25,861 $1.27 Million

Others Institutions Holding VCYT

# of Institutions

338

Shares Held

76.7M

Call Options Held

212K

Put Options Held

18.5K

View Full List

About VERACYTE, INC.

Ticker VCYT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,575,904
Market Cap $2.3B
Description
Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...

More about VCYT

Track Paul Tudor Jones's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tudor Investment Corp Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Tudor Investment Corp Et Al and Paul Tudor Jones with notifications on news.

Account